Roy Lewis, MD
Otolaryngology · Mooresville, NCNPI 1396728804
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $13,535 of the $17,618 with a category attached, or 76.8%. Neurent Medical Limited accounts for 79.0% of it on its own, with 29 other manufacturers making up the rest. Reporting peaked in 2024 at $14,945 and has fallen 94.1% since, to $881 in 2025. Among otolaryngology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 140 payments — averaging $125.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurent Medical Limited$14K
- Sanofi$560
- Inspire Medical Systems, Inc.$420
- Alk-abello, Inc$336
- Kaleo, Inc.$327
- Regeneron Healthcare Solutions, Inc.$317
- plus $2K from 24 others
What the payments were for
- Consulting fees$13,53577%
- Food & beverage$4,07723%
- Gifts$60%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurent Medical Limited | 10 | $13,921 |
| Sanofi | 15 | $560 |
| Inspire Medical Systems, Inc. | 6 | $420 |
| Alk-abello, Inc | 16 | $336 |
| Kaleo, Inc. | 16 | $327 |
| Regeneron Healthcare Solutions, Inc. | 9 | $317 |
| Optinose US, Inc. | 20 | $312 |
| Acclarent, Inc | 6 | $258 |
| Integra Lifesciences Corporation | 2 | $180 |
| GSK | 7 | $171 |
| Aerin Medical Inc. | 3 | $134 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $97 |
| Stryker | 4 | $90 |
| AstraZeneca | 1 | $84 |
| Hikma Pharmaceuticals USA | 3 | $64 |
| Oyster Point Pharma, Inc. | 2 | $49 |
| Medtronic | 2 | $36 |
| Paratek Pharmaceuticals, Inc. | 1 | $34 |
| Harrow Eye, LLC | 1 | $28 |
| Intersect ENT, Inc. | 2 | $25 |
| Alcon | 1 | $24 |
| AbbVie | 1 | $24 |
| Bausch & Lomb Americas Inc. | 1 | $22 |
| Novartis | 1 | $18 |
| Arbor Pharmaceuticals, Inc. | 1 | $18 |
| Alimera Sciences, Inc. | 1 | $17 |
| Smith+Nephew | 1 | $16 |
| Amgen | 1 | $15 |
| Merck | 1 | $15 |
| Forte Bio-pharma LLC | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEUROMARK Device$13,689
- NEUROMARK Radiofrequency Console$13,689
- DUPIXENT$361
- Inspire$186
- Acclarent Aera$165
- Inspira Air$165
- RELIEVA SPINPLUS NAV$165
- TruDi Probe$165
- Inspire Upper Airway Stimulation System$156
- TruDi Nav Cable$139
- Relieva Spinplus$139
- VIVAER STYLUS$109
- RHINAER STYLUS$109
How this compares
$17,618 in reported general payments places this provider in the 95th percentile of 362 otolaryngology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Epinephrine | 30 | $4,558 |
| Ipratropium Bromide | 154 | $3,924 |
| Mometasone Furoate | 48 | $2,665 |
| Dexlansoprazole DrDexlansoprazole | 12 | $1,811 |
| Azelastine Hcl | 57 | $1,546 |
| Fluticasone Propionate | 64 | $1,157 |
| Ofloxacin | 24 | $974 |
| Fluocinolone Acetonide Oil | 15 | $693 |
| Doxycycline Hyclate | 54 | $669 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 85 | $595 |
| Gabapentin | 76 | $547 |
| Montelukast Sodium | 43 | $535 |
| Mupirocin | 78 | $493 |
| Omeprazole | 58 | $450 |
| Clarithromycin | 14 | $332 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Hikma Pharmaceuticals USAEpinephrine | $64 | $4,55830 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 362 otolaryngology providers in North Carolina.
Other otolaryngology in Mooresville
- Herbert WettreichMooresville$5K
- David JangDurham$324K
- Robert FerrisRaleigh$258K
- Adam ZanationHickory$227K
- Brent SeniorChapel Hill$91K
- Charles EbertChapel Hill$57K
- Adam CampbellWinston Salem$47K
- Harold PillsburyChapel Hill$42K
- John BuentingSylva$30K
- Brendan O ConnellCharlotte$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.